Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyamines and brain tumors.

L J Marton

    National Cancer Institute Monograph
    |December 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Polyamines, linked to cell growth, may serve as biomarkers. Measuring polyamine levels in bodily fluids could help diagnose brain tumors and monitor treatment effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Polyamine-DNA Interactions: Possible Site of New Cancer Chemotherapeutic Intervention.

    Pharmaceutical research·2013
    Same author

    The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer.

    Cancer chemotherapy and pharmacology·2009
    Same author

    Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs.

    Amino acids·2007
    Same author

    Molecular basis of inward rectification: structural features of the blocker defined by extended polyamine analogs.

    Molecular pharmacology·2005
    Same author

    SL-11158, a synthetic oligoamine, inhibits polyamine metabolism of Encephalitozoon cuniculi.

    The Journal of eukaryotic microbiology·2002
    Same author

    Conformationally restricted analogues of 1N,14N-bisethylhomospermine (BE-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cells.

    Journal of medicinal chemistry·2001
    Same journal

    Forty-five years of cancer incidence in Connecticut: 1935-79.

    National Cancer Institute monograph·1986
    Same journal

    Second cancer following cancer of the breast in Connecticut, 1935-82.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following cancer of the respiratory system in Connecticut, 1935-1982.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following cancer of the digestive system in Connecticut, 1935-82.

    National Cancer Institute monograph·1985
    Same journal

    Summary: multiple primary cancers in Denmark, 1943-80.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.

    National Cancer Institute monograph·1985
    See all related articles

    Area of Science:

    • Biochemistry
    • Oncology
    • Neuroscience

    Background:

    • Polyamines are compounds associated with cellular proliferation and division.
    • A correlation exists between tissue polyamine synthesis and growth rate.
    • This suggests polyamine levels in physiological fluids might reflect tumor burden.

    Purpose of the Study:

    • To investigate the potential of polyamine levels in cerebrospinal fluid as biomarkers for brain tumors.
    • To assess the utility of polyamine determinations in diagnosing brain tumors and evaluating therapy.

    Main Methods:

    • Analysis of polyamine concentrations in cerebrospinal fluid.
    • Correlation of polyamine levels with the presence and characteristics of brain tumors.

    Main Results:

    Related Experiment Videos

    • Cerebrospinal fluid polyamine levels show a relationship with brain tumors.
    • These measurements may aid in early brain tumor diagnosis.

    Conclusions:

    • Polyamine determinations in cerebrospinal fluid show promise for brain tumor diagnosis.
    • These levels can assist in long-term evaluation of tumor therapy and short-term assessment of treatment efficacy.